The global proteomics market size reached US$ 36.3 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 126.2 Billion by 2032, exhibiting a growth rate (CAGR) of 14.85% during 2023-2032.
Proteomics refers to the study of proteomes, their structure and physiological functions on a large-scale. In 1994, Mark Wilkins first coined the term proteome for the proteins that are translated from genome, to denote the whole set of proteins synthesized within a living organism. It encompasses the modifications and alterations that take place in the existing protein when it is exposed to varying conditions.
Proteomics applies various technologies for the quantification and identification of proteins, along with the detection of diagnostic markers, understanding of pathogens in cells and interpretation of protein pathways in different diseases. It also evaluates the rate of protein production and the interaction patterns of proteins due to which it finds extensive applicability in drug discovery and the development of personalized medications.
The growing preference for personalized drugs, along with increasing research and development in drug discovery and biotechnology, is the key factor driving the growth of the market. Proteomic systems reduce the time, cost and resources needed for the chemical synthesis and biological testing of drugs and simplify the process of drug discovery. Furthermore, opportunities related to biomarker identification and mass spectrometry-based proteomics are favoring the market growth further. Additionally, the market is driven by increasing technological penetration in the comprehensive analysis of protein techniques.
These techniques include Electrospray Ionization-Liquid Chromatography-Mass Spectrometry (ESI-LC-MS), surface plasma resonance, microarray, protein fractionation systems and X-ray crystallography. These advancements enable a thorough quantitative and qualitative analysis of proteins and identification of cancer therapies and treatments. Other factors, such as favorable government policies for extensive research and development (R&D) are also augmenting the growth of the market.
2. What is the expected growth rate of the global proteomics market during 2024-2032?
3. What are the key factors driving the global proteomics market?
4. What has been the impact of COVID-19 on the global proteomics market?
5. What is the breakup of the global proteomics market based on the technology?
6. What is the breakup of the global proteomics market based on the end-user?
7. What are the key regions in the global proteomics market?
8. Who are the key players/companies in the global proteomics market?
Proteomics refers to the study of proteomes, their structure and physiological functions on a large-scale. In 1994, Mark Wilkins first coined the term proteome for the proteins that are translated from genome, to denote the whole set of proteins synthesized within a living organism. It encompasses the modifications and alterations that take place in the existing protein when it is exposed to varying conditions.
Proteomics applies various technologies for the quantification and identification of proteins, along with the detection of diagnostic markers, understanding of pathogens in cells and interpretation of protein pathways in different diseases. It also evaluates the rate of protein production and the interaction patterns of proteins due to which it finds extensive applicability in drug discovery and the development of personalized medications.
The growing preference for personalized drugs, along with increasing research and development in drug discovery and biotechnology, is the key factor driving the growth of the market. Proteomic systems reduce the time, cost and resources needed for the chemical synthesis and biological testing of drugs and simplify the process of drug discovery. Furthermore, opportunities related to biomarker identification and mass spectrometry-based proteomics are favoring the market growth further. Additionally, the market is driven by increasing technological penetration in the comprehensive analysis of protein techniques.
These techniques include Electrospray Ionization-Liquid Chromatography-Mass Spectrometry (ESI-LC-MS), surface plasma resonance, microarray, protein fractionation systems and X-ray crystallography. These advancements enable a thorough quantitative and qualitative analysis of proteins and identification of cancer therapies and treatments. Other factors, such as favorable government policies for extensive research and development (R&D) are also augmenting the growth of the market.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global proteomics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on analysis type, component type, technology, application and end-user.Breakup by Analysis Type:
- Structural Proteomics
- Functional Proteomics
- Protein Expression Proteomics
Breakup by Component Type:
- Core Proteomics Services
- Bioinformatics Software and Related Services
Breakup by Technology:
- Spectroscopy
- Chromatography
- Electrophoresis
- Protein Microarrays
- X-Ray Crystallography
- Surface Plasmon Resonance
- Others
Breakup by Application:
- Protein Expression Profiling
- Proteome Mining
- Post-translational Modifications
Breakup by End-User:
- Clinical Diagnostic Laboratories
- Research Organizations (Drug Discovery)
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, GE Healthcare Inc., Horiba Ltd., Luminex Corporation, Merck Group, Perkinelmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.Key Questions Answered in This Report
1. How big is the global proteomics market?2. What is the expected growth rate of the global proteomics market during 2024-2032?
3. What are the key factors driving the global proteomics market?
4. What has been the impact of COVID-19 on the global proteomics market?
5. What is the breakup of the global proteomics market based on the technology?
6. What is the breakup of the global proteomics market based on the end-user?
7. What are the key regions in the global proteomics market?
8. Who are the key players/companies in the global proteomics market?
Table of Contents
1 Preface3 Executive Summary13 Value Chain Analysis
2 Scope and Methodology
4 Introduction
5 Global Proteomics Market
6 Market Breakup by Analysis Type
7 Market Breakup by Component Type
8 Market Breakup by Technology
9 Market Breakup by Application
10 Market Breakup by End-User
11 Market Breakup by Region
12 SWOT Analysis
14 Porters Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Agilent Technologies Inc.
- Bio-RAD Laboratories Inc.
- Bruker Corporation
- Creative Proteomics
- Danaher Corporation
- GE Healthcare Inc.
- Horiba Ltd.
- Luminex Corporation
- Merck Group
- Perkinelmer Inc.
- Promega Corporation
- Thermo Fisher Scientific Inc.
- Waters Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 149 |
| Published | August 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 36.3 Billion |
| Forecasted Market Value ( USD | $ 126.2 Billion |
| Compound Annual Growth Rate | 14.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
